do glp 1 decrease alcohol cravings Could GLP-1 medications help transform treatment for addiction? Alcohol Use Disorder affects millions, yet there haven't been any new medications approved to treat it in 20 years. Now, new #CUAnschutz research CU Researcher Studying Effects of

A 2025 systematic review and meta-analysis in Reviews in Endocrine and Metabolic Disorders found that tirzepatide (the active ingredient in Mounjaro and Zepbound) reduced hsCRP by approximately 33% and IL-6 by approximately 18% compared to placebo across patients with and without diabetes. A growing body of research suggests this effect occurs through direct action on the NF-B pathway, a master switch of inflammation

By stimulating the release of growth hormone over a prolonged period, CJC-1295 helps improve body composition, increase energy, and support overall vitality

After meals, rinse your mouth with plain water if brushing is not immediately possible

Consistently, across different doses, male and female alike (Arans et al., 2023)

The FDA has warned that unapproved versions of GLP-1 drugs, including compounded semaglutide and tirzepatide, do not undergo FDA review for safety, effectiveness, or quality before being marketed, and that patients may face risks from products that have not been tested in large-scale clinical trials